Santa Monica Event Is December 7–9, 2011
(HealthNewsDigest.com) – Long Beach, CA – Robert Nagourney, MD, founder of Rational Therapeutics, Inc. (www.rationaltherapeutics.com), Long Beach, CA, is a featured speaker at The Farrah Fawcett Symposium on Circulating Tumor Cells and Chemosensitivity Testing, December 7 – 9, at Loews Beach Hotel, Santa Monica.
Sponsored by the Angeles Clinic Foundation, the symposium is a result of a generous gift from the Farrah Fawcett Foundation. Fawcett died in 2009 at St. John’s Health Center after a lengthy battle against cancer. The invitation only symposium will bring together the world’s prominent researchers in this area in order to raise awareness and explore current methods of cancer treatment including assays.
Dr. Nagourney, a board certified oncologist and hematologist and noted expert on chemosensitivity testing for more than 20 years, will highlight the lack of progress made in this arena due in part to the politics and economics of cancer treatment. “Physicians tend to follow standardized guidelines or ‘off the shelf treatments’ that provide the same traditional chemotherapy agent to every cancer patient. The treatments work adequately well, the schedules are established, the toxicities are well known, and no one is cured.”
Dr. Nagourney, who recently addressed the situation at a TEDx symposium (http://tedxtalks.ted.com/video/TEDxSoCal-Robert-Nagourney-MD-T), sees an overwhelming need to spread the message this conference will address – using the Ex Vivo Analysis of Programmed Cell Death (EVA-PCD®) platform, which provides a functional profile of how the cancer will respond to treatment.
Dr. Nagourney says, “Combining diagnostic skill with scientific insight, the physician becomes the captain of the ship.” He adds that laboratory-directed approaches can provide objective data that is then used to guide treatment selections. “Predicated upon an understanding of the patient’s tumor biology, cancer therapy becomes an intellectual exercise that draws upon literature and a knowledge of pharmacology and physiology,” he says.
To learn more about the symposium visit http://tacf.shermanpeck.com. For more information about Dr. Nagourney’s research, visit www.rational-t.com or his blog at http://robertanagourney.wordpress.com and on twitter @RobertNagourney.
About Rational Therapeutics
Founded in 1995, Rational Therapeutics is a pioneering cancer research laboratory specializing in personalized cancer care. The results of its Ex-Vivo Analysis—Programmed Cell Death (EVA-PCD®) platform creates a functional profile of a tumor’s sensitivity and resistance to various drugs and combinations. With this profile, an oncologist is equipped with the most accurate information to treat an individual’s cancer. Founder, Robert A. Nagourney, MD, an oncologist and hematologist, began researching cancer’s biology more than 25 years ago. His goal is to predict which treatments work best with the least toxicity to patients. Through his innovations, he has pioneered the art and science of personalized cancer care.
###
For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: [email protected] or 877-634-9180
HealthNewsDigest.com is syndicated worldwide and has over 7,000 journalists as subscribers.